Journals / Türkiye Çocuk Hastalıkları Dergisi / 2023 / Cilt: 17 Sayı: 4

COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case

COVID-19 İlişkili Akut İmmün Trombositopenik Purpura: Sıradışı Pediatrik Bir Olgu

Pages
324–327
Publication Date
2023-07-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, a case of pediatric acute ITP who was diagnosed during COVID-19 infection and had no signs of bleeding is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Immune thrombocytopenic purpura (ITP) is a hematological disease manifested by isolated thrombocytopenia.
📊
Key Findings & Data:After COVID-19 infection, various hematological complications can be seen, as well as the development of ITP.
💡
Conclusion & Impact:In this article, a case of pediatric acute ITP who was diagnosed during COVID-19 infection and had no signs of bleeding is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · çocuklar · immün trombositopenik purpura (İTP)

Abstract

Immune thrombocytopenic purpura (ITP) is a hematological disease manifested by isolated thrombocytopenia. Viral infections in the last month are often found in its etiology. After COVID-19 infection, various hematological complications can be seen, as well as the development of ITP. In this article, a case of pediatric acute ITP who was diagnosed during COVID-19 infection and had no signs of bleeding is presented.

Özet

İmmün trombositopenik purpura (İTP), izole trombositopeni ile kendini gösteren hematolojik bir hastalıktır. Etiyolojisinde son bir aydaki viral enfeksiyonlar sıklıkla bulunur. COVİD-19 enfeksiyonu sonrası çeşitli hematolojik komplikasyonların yanı sıra ITP gelişimi de görülebilmektedir. Bu yazıda COVİD-19 enfeksiyonu sırasında teşhis edilen ve kanama bulgusu olmayan bir çocuk akut ITP olgusu sunulmaktadır.

🔖

Cite This Article

GÜNEŞ, Ö., GÜNEY, A. Y., GÜDER, L., MUSTAFAOĞLU, Ö., BAYRAKTAR, P., ŞAHİN, S., YÜKSEK, S. K., GÜLHAN, B., BAYHAN, G. İ., PARLAKAY, A. Ö. (2023). COVID-19-Associated Acute Immune Thrombocytopenic Purpura: An Unusual Pediatric Case. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 17 Sayı: 4, 324–327. https://ajindex.com/articles/956348

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. Intercontinental Childhood ITP Study Group; Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143:605-8.
  2. Zeller B, Rajantie J, Hedlund-Treutiger I, Tedgård U, Wesenberg F, Jonsson OG, et al. NOPHO ITP. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005;94:178-4.
  3. Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E. Immune Thrombocytopenic Purpura in a Patient with Covid-19. N Engl J Med 2020;382:e43. Lévesque V, Millaire É, Corsilli D, Rioux-Massé B, Carrier FM. Severe immune thrombocytopenic purpura in critical COVID-19. Int J Hematol 2020;112:746-50.
  4. Bomhof G, Mutsaers PGNJ, Leebeek FWG, Te Boekhorst PAW, Hofland J, Croles FN, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol 2020;190:e61-4. D’Orazio JA, Neely J, Farhoudi N. ITP in children: pathophysiology and current treatment approaches. J Pediatr Hematol Oncol 2013;35:1-13. O’Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, et al. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics 2012;129:248-55. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-96.
  5. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-86.
  6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20.
  7. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 2020;506:145-8.
  8. Tsao HS, Chason HM, Fearon DM. Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2. Pediatrics 2020;146:e20201419. Rosenzweig JD, McThenia SS, Kaicker S. SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the